Wetherby Asset Management Inc
- SEC CIK
- 0001279627
- Latest filing
- Nov 14, 2025
TAK holding history
Takeda Pharmaceutical Co Ltd in every 13F filed by Wetherby Asset Management Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
TAK overviewAll 13F holders of TAKFull Q3 2025 holdings
- Shares (Q3 2025)
- 38,074
- Value
- $557.4K
- % of portfolio
- <0.1%
- Quarters held
- 18
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2025 | 38,074 | $557.4K | <0.1% | −6,794−15.1% | Reduced | Holders |
| Q2 2025 | 44,868 | $693.7K | <0.1% | – | No prior filing | Holders |
| Q1 2025 | – | – | – | – | Not filed | Holders |
| Q4 2024 | 39,220 | $519.3K | <0.1% | +5,167+15.2% | Added | Holders |
| Q3 2024 | 34,053 | $484.2K | <0.1% | −6,738−16.5% | Reduced | Holders |
| Q2 2024 | 40,791 | $527.8K | <0.1% | −42,207−50.9% | Reduced | Holders |
| Q1 2024 | 82,998 | $1.15M | 0.1% | −3,785−4.4% | Reduced | Holders |
| Q4 2023 | 86,783 | $1.24M | 0.1% | −14,235−14.1% | Reduced | Holders |
| Q3 2023 | 101,018 | $1.56M | 0.1% | −6,201−5.8% | Reduced | Holders |
| Q2 2023 | 107,219 | $1.68M | 0.1% | −5,224−4.6% | Reduced | Holders |
| Q1 2023 | 112,443 | $1.85M | 0.1% | +10,361+10.1% | Added | Holders |
| Q4 2022 | 102,082 | $1.59M | 0.1% | −1,345−1.3% | Reduced | Holders |
| Q3 2022 | 103,427 | $1.34M | 0.1% | +13,512+15.0% | Added | Holders |
| Q2 2022 | 89,915 | $1.26M | 0.1% | −54,292−37.6% | Reduced | Holders |
| Q1 2022 | 144,207 | $2.06M | 0.1% | +72,282+100.5% | Added | Holders |
| Q4 2021 | 71,925 | $980.0K | 0.1% | +4,736+7.0% | Added | Holders |
| Q3 2021 | 67,189 | $1.10M | 0.1% | +9,099+15.7% | Added | Holders |
| Q2 2021 | 58,090 | $978.0K | 0.1% | +16,714+40.4% | Added | Holders |
| Q1 2021 | 41,376 | $755.0K | 0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.